Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) EBT: 2018-2024

Historic EBT for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to -$55.6 million.

  • Gossamer Bio's EBT fell 51.00% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$159.6 million, marking a year-over-year increase of 4.31%. This contributed to the annual value of -$55.6 million for FY2024, which is 69.06% up from last year.
  • According to the latest figures from FY2024, Gossamer Bio's EBT is -$55.6 million, which was up 69.06% from -$179.8 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's EBT ranged from a high of -$55.6 million in FY2024 and a low of -$243.2 million during FY2020.
  • For the 3-year period, Gossamer Bio's EBT averaged around -$154.9 million, with its median value being -$179.8 million (2023).
  • Per our database at Business Quant, Gossamer Bio's EBT slumped by 33.24% in 2020 and then soared by 69.06% in 2024.
  • Gossamer Bio's EBT (Yearly) stood at -$243.2 million in 2020, then rose by 3.45% to -$234.8 million in 2021, then climbed by 2.31% to -$229.4 million in 2022, then climbed by 21.61% to -$179.8 million in 2023, then skyrocketed by 69.06% to -$55.6 million in 2024.